Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis.
Dermatology reports(2022)
摘要
not available
更多查看译文
关键词
Biological therapy,Cancer,Guselkumab,IL-23,Neoplasia,Psoriasis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要